BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28943442)

  • 1. The quest for exceptional drug solubilization in diluted surfactant solutions and consideration of residual solid state.
    Saal W; Wyttenbach N; Alsenz J; Kuentz M
    Eur J Pharm Sci; 2018 Jan; 111():96-103. PubMed ID: 28943442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubilization behavior of a poorly soluble drug under combined use of surfactants and cosolvents.
    Kawakami K; Oda N; Miyoshi K; Funaki T; Ida Y
    Eur J Pharm Sci; 2006 May; 28(1-2):7-14. PubMed ID: 16406526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micellar solubilization of poorly water-soluble drugs: effect of surfactant and solubilizate molecular structure.
    Vinarov Z; Katev V; Radeva D; Tcholakova S; Denkov ND
    Drug Dev Ind Pharm; 2018 Apr; 44(4):677-686. PubMed ID: 29164955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-solubilization of poorly soluble drugs by micellization and complexation.
    Rao VM; Nerurkar M; Pinnamaneni S; Rinaldi F; Raghavan K
    Int J Pharm; 2006 Aug; 319(1-2):98-106. PubMed ID: 16765542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Modeling of Micellar Solubilization by Single and Mixed Nonionic Surfactants.
    Feng S; Catron ND; Zhu AD; Lipari JM; Wu J; Gao Y; Zhang GGZ
    J Pharm Sci; 2018 Aug; 107(8):2079-2090. PubMed ID: 29548976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Micellar Surfactant on Supersaturation and Insight into Solubilization Mechanisms in Supersaturated Solutions of Atazanavir.
    Indulkar AS; Mo H; Gao Y; Raina SA; Zhang GGZ; Taylor LS
    Pharm Res; 2017 Jun; 34(6):1276-1295. PubMed ID: 28352994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of drug supersaturation for rational early formulation screening of surfactant/co-solvent drug delivery systems.
    Stillhart C; Cavegn M; Kuentz M
    J Pharm Pharmacol; 2013 Feb; 65(2):181-92. PubMed ID: 23278685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental and theoretical investigation of the micellar-assisted solubilization of ibuprofen in aqueous media.
    Stephenson BC; Rangel-Yagui CO; Pessoa Junior A; Tavares LC; Beers K; Blankschtein D
    Langmuir; 2006 Feb; 22(4):1514-25. PubMed ID: 16460069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albendazole solution formulation via vesicle-to-micelle transition of phospholipid-surfactant aggregates.
    Vinarov Z; Gancheva G; Katev V; Tcholakova SS
    Drug Dev Ind Pharm; 2018 Jul; 44(7):1130-1138. PubMed ID: 29412014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study on solubilization of poorly soluble drugs by cyclodextrins and micelles: complexation and binding characteristics of sulfamethoxazole and trimethoprim.
    Göktürk S; Çalışkan E; Talman RY; Var U
    ScientificWorldJournal; 2012; 2012():718791. PubMed ID: 22649316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solubilization of flurbiprofen in pH-surfactant solutions.
    Li P; Zhao L
    J Pharm Sci; 2003 May; 92(5):951-6. PubMed ID: 12712414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mechanistic study of griseofulvin dissolution into surfactant solutions under laminar flow conditions.
    Rao VM; Lin M; Larive CK; Southard MZ
    J Pharm Sci; 1997 Oct; 86(10):1132-7. PubMed ID: 9344170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Surfactant-Bile Interactions on the Solubility of Hydrophobic Drugs in Biorelevant Dissolution Media.
    Vinarov Z; Katev V; Burdzhiev N; Tcholakova S; Denkov N
    Mol Pharm; 2018 Dec; 15(12):5741-5753. PubMed ID: 30351956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant-mediated dissolution: contributions of solubility enhancement and relatively low micelle diffusivity.
    Balakrishnan A; Rege BD; Amidon GL; Polli JE
    J Pharm Sci; 2004 Aug; 93(8):2064-75. PubMed ID: 15236455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current perspectives of solubilization: potential for improved bioavailability.
    Mallick S; Pattnaik S; Swain K; De PK
    Drug Dev Ind Pharm; 2007 Aug; 33(8):865-73. PubMed ID: 17729104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering cocrystal solubility, stability, and pH(max) by micellar solubilization.
    Huang N; Rodríguez-Hornedo N
    J Pharm Sci; 2011 Dec; 100(12):5219-34. PubMed ID: 21910122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of sodium dodecyl sulphate on the dissolution of poorly soluble drug into biorelevant medium from drug-surfactant discs.
    Madelung P; Ostergaard J; Bertelsen P; Jørgensen EV; Jacobsen J; Müllertz A
    Int J Pharm; 2014 Jun; 467(1-2):1-8. PubMed ID: 24594297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the solubilization of gliclazide by aqueous micellar solutions.
    Alkhamis KA; Allaboun H; Al-Momani WY
    J Pharm Sci; 2003 Apr; 92(4):839-46. PubMed ID: 12661069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems.
    Cirri M; Mura P; Mora PC
    Int J Pharm; 2007 Aug; 340(1-2):84-91. PubMed ID: 17531411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.